Reversing Endogenous Alloreactive B Cell GC Responses With Anti-CD154 or CTLA-4Ig
Open Access
- 4 September 2013
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 13 (9), 2280-2292
- https://doi.org/10.1111/ajt.12350
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an updateBiologics: Targets and Therapy, 2012
- Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memoryThe Journal of Experimental Medicine, 2012
- Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal TransplantationDrugs, 2012
- MHC Class II TetramersPublished by The American Association of Immunologists ,2012
- A germinal center–independent pathway generates unswitched memory B cells early in the primary responseThe Journal of Experimental Medicine, 2012
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2012
- Chronic alloantibody mediated rejectionSeminars in Immunology, 2011
- An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signalingMolecular Systems Biology, 2011
- In situ identification of allospecific B cells using pentamersBlood, 2008
- Germinal Center Marker GL7 Probes Activation-Dependent Repression of N-Glycolylneuraminic Acid, a Sialic Acid Species Involved in the Negative Modulation of B-Cell ActivationMolecular and Cellular Biology, 2007